Market closed

Kenvue /$KVUE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Kenvue

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Ticker

$KVUE
Sector
Consumer Staples

Trading on

NYSE

Industry

Personal Care Products
Headquarters
Skillman, United States

Employees

22,000
Website
www.kenvue.com

Kenvue Metrics

BasicAdvanced
$40B
37.94
$0.55
-
$0.81
3.91%

$40B

$24.05

$17.67

11M

$0.81

0.999

0.58

67.071

82.929

144.92%

5.35%

6.76%

9.88%

37.944

2.598

3.78

-5.33

28.666

3.86%

3.91%

-0.55%

-41.30%

What the Analysts think about Kenvue

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Kenvue stock.

Kenvue Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Kenvue Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Kenvue News

AllArticlesVideos
Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer'

Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer'

Seeking Alpha·1 week ago
Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips

Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips

24/7 Wall Street·2 weeks ago
Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends

Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends

Seeking Alpha·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KVUE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kenvue stock?

Kenvue (KVUE) has a market cap of $40B as of January 15, 2025.

What is the P/E ratio for Kenvue stock?

The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 37.94 as of January 15, 2025.

Does Kenvue stock pay dividends?

Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.81 and the yield is 3.91%. Kenvue has a payout ratio of 144.92% on a trailing twelve-month basis.

When is the next Kenvue dividend payment date?

The next Kenvue (KVUE) dividend payment date is unconfirmed.

What is the beta indicator for Kenvue ?

Kenvue (KVUE) does not currently have a Beta indicator.